Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 182.05 ($2.40) and traded as high as GBX 221 ($2.92). Faron Pharmaceuticals Oy shares last traded at GBX 215 ($2.84), with a volume of 2,900 shares traded.
Faron Pharmaceuticals Oy Price Performance
The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55. The stock has a market cap of £224.93 million, a P/E ratio of -671.88 and a beta of 0.36. The firm has a 50 day moving average price of GBX 182.05 and a 200 day moving average price of GBX 154.59.
About Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Featured Articles
- Five stocks we like better than Faron Pharmaceuticals Oy
- What is the NASDAQ Stock Exchange?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
